Private Harbour Investment Management & Counsel’s Teva Pharmaceuticals TEVA Stock Holding History

Private Harbour Investment Management & Counsel’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-8,970	Closed	-$413K	–	87
2016 Q3	$413K	Sell	8,970 -1,000	-10%	-$52.2K	0.35%	71
2016 Q2	$501K	Hold	9,970	–	–	0.41%	68
2016 Q1	$533K	Sell	9,970 -500	-5%	-$29.3K	0.48%	61
2015 Q4	$687K	Sell	10,470 -280	-3%	-$17.3K	0.57%	52
2015 Q3	$607K	Hold	10,750	–	–	0.5%	56
2015 Q2	$635K	Sell	10,750 -195	-2%	-$12K	0.45%	60
2015 Q1	$681K	Sell	10,945 -610	-5%	-$35.5K	0.46%	62
2014 Q4	$665K	Sell	11,555 -5,675	-33%	-$316K	0.46%	59
2014 Q3	$926K	Sell	17,230 -50	-0.3%	-$2.65K	0.57%	58
2014 Q2	$906K	Sell	17,280 -1,000	-5%	-$51.1K	0.54%	62
2014 Q1	$966K	Buy	18,280 +1,550	+9%	+$71.6K	0.63%	59
2013 Q4	$671K	Sell	16,730 -9,300	-36%	-$366K	0.43%	63
2013 Q3	$983K	Sell	26,030 -2,353	-8%	-$91.8K	0.67%	55
2013 Q2	$1.11M	Buy	+28,383	New	+$1.11M	0.8%	47

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Private Harbour Investment Management & Counsel's TEVA Position: Q4 2016 in Review

Private Harbour Investment Management & Counsel sold out of Teva Pharmaceuticals (TEVA) in Q4 2016, closing a stake of 8,970 shares — an estimated $413K sold.

Private Harbour Investment Management & Counsel first reported a position in TEVA in Q2 2013 and held it in 14 quarters. The position peaked at $1.11M in Q2 2013. 738 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

Private Harbour Investment Management & Counsel reported no remaining Teva Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Private Harbour Investment Management & Counsel sold 8,970 Teva Pharmaceuticals shares in Q4 2016, an estimated $413K.
Private Harbour Investment Management & Counsel first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 14 quarters.
Private Harbour Investment Management & Counsel's Teva Pharmaceuticals position peaked at $1.11M in Q2 2013.
738 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on Private Harbour Investment Management & Counsel's 13F filing for Q4 2016, filed 10 Feb 2017.